Patent dispute on Interferon anticancer drug ended.

A 8 year patent dispute on Interferon between Cheil Jedang and Roche, a Swiss multinational pharmaceutical corporation, has been ended recently.

The 2nd division of the Supreme Court (Chief Chancellor: Cho Moo-jae) made final confirmation on the judgement at the low court in favor of accuser filed last year (Cheil Jedang) over the patent nullification of Interferon registered by Roche, a Swi...